REDWOOD CITY, Calif. (AP) _ Guardant Health Inc. (GH) on Tuesday reported a loss of $25.1 million in its fourth quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of 30 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.
The provider of oncology testing services posted revenue of $32.9 million in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $24.6 million.
For the year, the company reported a loss of $85.1 million, or $2.80 per share. Revenue was reported as $90.6 million.
Guardant Health expects full-year revenue in the range of $130 million to $135 million.
Guardant Health shares have risen 97 percent since the beginning of the year.
No comments:
Post a Comment